Wildcat Capital Management, LLC Quant / Systematic

CIK: 0001582384 · Show all filings

Period: Q1 2025 (← Previous) (Next →)

Filing Date: May 2, 2025

Total Value ($000): $187,388 (100.0% shares, 0.0% debt)

Holdings (8)

ULCC FRONTIER GROUP HLDGS INC 65.0%

Value ($000) $121,786 Shares 28,061,351 Est. Cost $5.99 Unrealized +24.2%

RLX RLX TECHNOLOGY INC 18.1%

Value ($000) $33,927 Shares 18,046,195 Est. Cost $4.05 Unrealized —

TIC ACUREN CORP 8.9%

Value ($000) $16,680 Shares 1,500,000 Est. Cost $12.06 Unrealized 0.0%

URGN UROGEN PHARMA LTD 2.9%

Value ($000) $5,481 Shares 495,606 Est. Cost $34.01 Unrealized -68.6%

ALLO ALLOGENE THERAPEUTICS INC 2.3%

Value ($000) $4,264 Shares 2,920,787 Est. Cost $17.44 Unrealized -89.2%

CNTA CENTESSA PHARMACEUTICALS PLC 2.2%

Value ($000) $4,053 Shares 281,859 Est. Cost $14.38 Unrealized —

— KRONOS BIO INC 0.6%

Value ($000) $1,071 Shares 1,297,959 Est. Cost $29.87 Unrealized —

— SILEXION THERAPEUTICS CORP 0.1%

Value ($000) $125 Shares 113,428 Est. Cost $2.01 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
ULCC	FRONTIER GROUP HLDGS INC	28,061,351	$121,786	65.0%	$5.99	+24.2%	COM	35909R108
RLX	RLX TECHNOLOGY INC	18,046,195	$33,927	18.1%	$4.05	—	SPONSORED ADS	74969N103
TIC	ACUREN CORP	1,500,000	$16,680	8.9%	$12.06	0.0%	COM	00510N102
URGN	UROGEN PHARMA LTD	495,606	$5,481	2.9%	$34.01	-68.6%	COM	M96088105
ALLO	ALLOGENE THERAPEUTICS INC	2,920,787	$4,264	2.3%	$17.44	-89.2%	COM	019770106
CNTA	CENTESSA PHARMACEUTICALS PLC	281,859	$4,053	2.2%	$14.38	—	SPONSORED ADS	152309100
—	KRONOS BIO INC	1,297,959	$1,071	0.6%	$29.87	—	COM	50107A104
—	SILEXION THERAPEUTICS CORP	113,428	$125	0.1%	$2.01	—	SHS NEW	G1281K122